Sree Rayalaseema Hi-Strength Hypo Limited (NSE:SRHHYPOLTD)
510.00
+9.05 (1.81%)
Aug 12, 2026, 9:25 AM IST
NSE:SRHHYPOLTD Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 6,670 | 6,670 | 6,378 | 8,660 | 16,501 | 12,673 |
Revenue Growth | 4.57% | 4.57% | -26.35% | -47.52% | 30.21% | 39.13% |
Gross Profit Gross Profit Growth | 3,335 | 3,335 | 2,255 | 2,467 | 3,519 | 2,998 |
Operating Income Operating Income Growth | 812.32 | 812.32 | 869.29 | 1,015 | 1,615 | 1,301 |
Net Income Net Income Growth | 901.45 | 901.45 | 900.72 | 790.62 | 1,543 | 1,028 |
Earnings Per Share EPS Growth | 53.25 | 53.25 | 52.47 | 46.06 | 89.87 | 59.88 |
EPS Growth | 1.48% | 1.48% | 13.93% | -48.74% | 50.08% | 69.68% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Chemicals Chemicals Growth | 6,670 | 6,670 | 6,233 | 6,536 | 8,735 | 7,918 |
Trading Trading Growth | - | - | 88.62 | 2,243 | 7,178 | 4,617 |
Power Generation Power Generation Growth | - | - | 56.88 | 687.11 | 949.9 | 469.68 |
Unallocated Unallocated Growth | - | - | 394.71 | 221.48 | - | - |
Total Total Growth | 6,670 | 6,670 | 6,773 | 8,882 | 16,501 | 12,673 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 4,388 | 4,388 | 3,690 | 3,293 | 2,264 | 142.48 |
Total Debt Total Debt Growth | 116.11 | 116.11 | 157.43 | 129.21 | 191.71 | 283.63 |
Net Cash (Debt) Net Cash Growth | 4,272 | 4,272 | 3,532 | 3,164 | 2,073 | -141.15 |
Net Cash Growth | 20.94% | 20.94% | 11.65% | 52.65% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 252.35 | 252.35 | 205.78 | 184.31 | 120.75 | -8.22 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 391.76 | 391.76 | 654.83 | 1,397 | 1,414 | 597.5 |
Capital Expenditures CapEx Growth | -63.39 | -63.39 | -24.34 | -200.27 | -83.18 | -144.05 |
Free Cash Flow Free Cash Flow Growth | 328.37 | 328.37 | 630.49 | 1,197 | 1,331 | 453.45 |
Free Cash Flow Growth | -47.92% | -47.92% | -47.31% | -10.10% | 193.52% | -9.53% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 50.00% | 50.00% | 35.36% | 28.49% | 21.33% | 23.66% |
Operating Margin | 12.18% | 12.18% | 13.63% | 11.72% | 9.79% | 10.27% |
Pretax Margin | 18.12% | 18.12% | 18.68% | 12.39% | 11.54% | 10.81% |
Profit Margin | 13.52% | 13.52% | 14.12% | 9.13% | 9.35% | 8.11% |
FCF Margin | 4.92% | 4.92% | 9.88% | 13.82% | 8.07% | 3.58% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 3.000 | 3.000 | 3.000 | 3.000 | 4.000 | 3.500 |
Dividend Per Share Growth | 0% | 0% | 0% | -25.00% | 14.29% | 16.67% |
Dividend Yield | 0.60% | 0.78% | 0.61% | 0.62% | 0.99% | 0.76% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 9.40 | 7.31 | 9.38 | 10.69 | 4.56 | 7.91 |
P/FCF Ratio | 26.19 | 20.07 | 13.40 | 7.06 | 5.29 | 17.92 |
PS Ratio | 1.29 | 0.99 | 1.33 | 0.98 | 0.43 | 0.64 |